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Helicobacterpylori and Apoptosis
Steven F. Moss
Division ofGastroenterology, Department ofMedicine, St. Luke's-Roosevelt
Hospital Center/Columbia University, New York, New York
In an attempt to understand the diverse effects of infection with Helicobacter
pylori on epithelial mucosal mass and consequent clinical outcome, the rela-
tionship between H. pylori infection and gastric epithelial cellular turnover has
been investigated. Our results indicate that H. pylori increases epithelial cell
proliferation and apoptosis in vivo, but that infection with bacteria of the cagA
genotype leads to relatively more proliferation than apoptosis. This review
explores the causes ofthe induction ofapoptosis in gastric epithelial cells by H.
pylori and the consequences of alterations in apoptosis to the maintenance of
gastric mucosal homeostasis.
INTRODUCTION
How does infection by Helicobacterpylori produce such diverse clinical outcomes?
Most ofthe world's population are chronically infected with this organism, yet fewer than
one fifth develop ulcers during their lifetime and only a very small percentage, perhaps
one to two percent, will develop cancer or lymphoma. The remainder continue to have a
chronic gastritis over decades, with progression to chronic atrophy in about one half of
these and intestinal metaplasia in around a tenth. However, most people infected are
unlikely to develop any clinical consequences of their infection and die ultimately of an
unrelated cause [1, 2, 3].
In recent years, much attention has focused on the role of possible bacterial patho-
genesis factors in determining clinical outcome. These bacterial virulence factors include
the vacuolating cytotoxin, vacA, and more lately, cagA, together with associated genes on
the cagA pathogenicity island. However, although there is an association between vacA
and cagA, and the incidence ofulcers and cancer in many populations, it is clear that the
presence of these proteins does not account for all the disease associations. For example,
although patients with ulcers are in general infected with cagA positive/vac A positive
strains, many individuals harboring bacteria with this phenotype do not have ulcers, and
in some parts of the world where the incidence of gastric cancer is very high, almost
everyone is infected with cagA positive strains yet cancer is notuniversal [4]. Recent work
in animal models has demonstrated that host factors may be just as important in deter-
mining outcome. Forexample, inbred strains ofmice respond quite differently to the same
infection with H.felis. Some strains had an intense inflammatory response, while only one
ofthree strains developed erosions, a phenomenon only partially related to the MHC hap-
lotype [5].
We have been interested in exploring the possibility that the outcome of infection is
determined not only by the bacterium but by the interaction between bacterium and
epithelium. Thus, interactions leading to epithelial cell loss would be expected to cause
atrophy or ulceration, while interactions leading to excessive epithelial cell growth may
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predispose to cancer. Such models are based upon the recentrecognition ofthe importance
of programmed cell death (apoptosis) in the maintenance of tissue homestasis in organs
undergoing cellular turnover, such as the gastrointestinal tract.
EPITHELIAL APOPTOSIS IN THE GASTROINTESTINAL TRACT
It is being increasingly appreciated that tissue mass is dependent not only upon new
cell production by cell proliferation. To maintain tissue integrity and homeostasis, the rate
ofcell proliferation needs to be balanced by the rate ofcell loss [6]. It is now believed that
in the normal gastrointestinal tract, cells are lost not by passive shedding into the lumen,
but by an active energy-requiring cell suicide program termed "apoptosis." A renewed
interest in examining cell loss in the gastrointestinal tract has occurred in part because of
our increasing ability to recognize cells undergoing apoptosis. Although histologists had
been familiar with nuclear pyknosis and karyorrhexis for decades, the phenomenon of
non-necrotic cell death and the use of the term apoptosis to describe it are much more
recent. In retrospect, it is clear that what pathologists were in many cases describing in a
variety of different organs were apoptotic cells. For example, Councilman bodies in the
liver, karyolytic bodies in intestinal crypts and so on [7]. Among the earliest papers look-
ing at apoptosis in the gastrointestinal tract are those of Elmes [8], and Potten and co-
workers, who examined the effect ofDNA damaging agents on apoptosis in the small and
large intestines ofrodents [9]. Until very recently, however, apoptosis intissues couldonly
be assessed by light microscopy ofH&E stained sections or by electron microscopy. Both
have their drawbacks, the former related to the extreme difficulty of detecting apoptotic
cells in the presence of inflammation and the latter being non-quantitative. The develop-
ment of an in situ histochemical assay to stain cells carrying DNA strand breaks, one of
the major hallmarks of apoptosis, by Gavrieli and colleagues in 1992 [10], led to the
appreciation that apoptosis was a common event in the gastrointestinal tract [11]. The
recognition that apoptosis is an important physiological process in the gut, as in other tis-
sues, together with the ability to identify apoptotic cells has led to considerable interest in
the possibility that alterations in apoptosis may be important in the pathogenesis of gas-
trointestinal disease [12].
H. PYLORI, LIFE AND DEATH IN THE STOMACH
In the stomach, new cells are produced from the proliferative zone located at the base
of gastric pits and migrate upward towards the lumen, where they differentiate and ulti-
mately undergo apoptosis after about one week. There is also a downward, slower, migra-
tion ofcells, ending in apoptosis and probably phagocytosis at the base ofthe glands after
one to two months. Thus, cell proliferation and apoptosis are intimately interrelated, rep-
resenting opposite ends ofthe cells' life cycle. Increased rates ofcell proliferation would,
therefore, produce a greater mass oftissue, unless balanced by increased rates of apopto-
sis, and conversely, increased rates of cell death may be responsible for stimulating
increased cell proliferation. A balanced, homeostatic relationship between proliferation
and apoptosis allows the gastrointestinal tract to adjust for damage due to luminal insults
and serves to prevent cell accumulation where cell proliferation is excessive. Although
apoptosis is commonly viewed as the physiological endpoint ofthe cell life span, there is
also evidence in the gastrointestinal tract, at least, that apoptosis may be activated early in
the cell's life span as a self-defense mechanism to eliminate cells carrying mutations. This
"altruistic" cell death occurs after DNA damage induced by irradiation or mutagenic
drugs, for example and is dependent upon p53 [13].
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What is the relevance ofgastric apoptosis to the pathogenesis ofH. pylori? Increased
cell proliferation rates have been noted in all stages of the gastric preneoplastic process,
including atrophic gastritis, intestinal metaplasia, gastric dysplasia and gastric carcinoma
[14]. Several recent studies have clearly demonstrated, using a variety of different cell
proliferation markers, that the number ofproliferating gastric epithelial cells is increased
in the presence of H. pylori infection and that this can be normalized by the eradication
ofH. pylori, suggesting that the organism orthe associated gastritis is responsible for this
phenomenon [15-20]. We have confirmed this in a group ofduodenal ulcerpatients, mea-
suring epithelial cell proliferation rate using the Mib-1 antibody to detect cells express-
ing the Ki-67 cell proliferation-associated antigen. In this study, patients were examined
bothbefore and after treatment with bismuth-based triple therapy, and thus served as their
own controls (Figure 1). The eradication ofH. pylori was associated with a marked reduc-
tion in the numbers of proliferating gastric epithelial cells (Figure 2). Since H. pylori
increases cell proliferation wherever examined, why is there not exuberant gastric mucos-
al growth in patients infected by H. pylori?-could this be because H. pylori-increased
proliferation is a response to increased apoptosis? Furthermore, although H. pylori
increases cell proliferation in vivo, most studies have demonstrated that, in vitro, adding
H. pylori to gastric epithelial cells in culture results in an inhibition of cell growth and
proliferation [21-23]. Could this reflect the induction of apoptosis by H. pylori?
THE EFFECT OF H. PYLORI ON GASTRIC APOPTOSIS
To examine the effects ofH. pylori on epithelial cell apoptosis in vivo, we used in-situ
terminal deoxyuridine nucleotide nick end-labeling (the TUNEL method) to stain apop-
totic cells in gastric antral biopsies. As forproliferation, we examined apoptosis in patients
with duodenal ulcer disease, comparing the same patients before and after treatment [24].
Apoptotic cells could be identified in gastric antral biopsies and were normally located at
the luminal end ofthe gastric gland. In H. pylori associated antral gastritis, the number of
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Figure 1. Proliferating cells in gastric antral mucosa, stained with the Mib-1 antibody against
the Ki-67 antigen. Before eradication of H. pylori, numerous proliferating cells are present in an
expanded proliferative zone (a, left), nuclear Ki-67 immunoreactivity can be appreciated better at
higher power (b, middle). Aftereradication ofH. pylori the numberofproliferating cells is marked-
ly decreased (c, right). Original magnification x 200 (a, c); x 500 (b).
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Figure 2. Effect oferadication ofH.pylori on gastric epithelial cell proliferation, measured by
immunostaining with the Mib-1 antibody. Bars represent the mean values.
apoptotic epithelial cells was increased, and apoptotic cells could be seen spread through-
out the entire gland. Furthermore, there were increased numbers of apoptotic cells in the
inflammatory infiltrate, although the increased number of apoptotic epithelial cells in H.
pylori gastritis was not related to the degree of inflammation. After the eradication ofH.
pylori, the increased number ofapoptotic cells was reduced significantly and became sim-
ilar to a group ofH. pylori-negative dyspeptic controls (Figure 3). It shouldbe noted, how-
ever, that although the mean number ofapoptotic cells was increased in H. pylori gastritis;
this was because around halfofthe patients had increased numbers ofapoptotic cells, but
halfhad numbers similar to those ofcontrols. In fact, there was a poorcorrelation between
the numbers ofproliferating cells and apoptotic cells from serial sections ofthe same biop-
sies (r = .027, p = .07), with two apparent groups: one with high numbers ofproliferation
cells but few apoptotic cells, and another group with greatly increased numberofboth pro-
liferating cells and apoptotic cells (Figure 4). In a further study in collaboration with Dr
Peek and colleagues at Vanderbilt University, we have evaluated the relationship between
apoptosis and proliferation in a larger group ofpatients prospectively, and found that the
two groups described above may represent the outcome ofinfection withcagA positive and
cagA negative strains [25]. Proliferation was increasedinbothcagA positive andcagA neg-
ative strains, compared with normals but was greatest in the cagA positive infected
mucosa. Apoptosis was increased only by cagA negative strains and in cagA positive cases
was not significantly different to normal. A strong concordance was found between the
presence of cagA positivity and the vacA sla signal sequence, so that these relationships
held when the data were reanalyzed for the vacA sla signal sequence. Thus, cagA-nega-
tive H. pylori infection is associated with both increased apoptosis and increased prolifer-
ation, whereas in the cagA positive group there was an apparent imbalance between the
two, with increased rates of cell proliferation unaccompanied by increased apoptosis.
Ultimately, an imbalance between increased proliferation, but relatively normal apoptosis
could lead to unrestrained tissue growth and even neoplasia.
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Figure 3. Figure 3. Effect of eradication ofH. pyloni on gastric epithelial cell apoptosis, mea-
sured by the TUNEL assay. Bars represent the mean values. At right are the results (mean + stan-
dard deviation) of a group of 12 non-ulcer dyspeptic controls. From [24] with permission.
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Figure 4. Relationship between apoptosis and proliferation in duodenal ulcer patients, before
and after eradication therapy.
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Figure 5. The regulation of apoptosis-a simplified schema. ECM = extracellular matrix; (E =
specific cell surface receptor. See text for details.
THE REGULATION OF APOPTOSIS
Apoptosis is a highly organized and regulated process requiring transcriptional reg-
ulation, new protein expression and the utilization ofenergy stores. The net effect of sev-
eral stimulatory and inhibitory pathways determines whether apoptosis occurs, and exam-
ining the effect of H. pylori on these pathways may be helpful in understanding how H.
pylori alters gastric epithelial cell apoptosis. Although our studies so far have indicated
that bacterial factors may be important in determining the extent ofapoptosis, it is possi-
ble that the effects we have seen are related not directly to bacteria but to the associated
inflammatory response. Figure 5 summarizes some ofthe key determinants of apoptosis.
The endogenous apoptosis pathways may be activated by the detection of DNA damage
by wild type p53. In gastric carcinogenesis, where p53 is lost or mutated, the ability to
detect and react to DNA damage will be impaired and apoptosis may be either activated
inappropriately or inhibited. A second pathway to apoptosis involves the external stimu-
lus ofgrowth factors and the extracellular matrix. Most growth factors in the stomach are
thought to stimulate proliferation and/or inhibit apoptosis, such as hepatocyte growth fac-
tor ortransforming growth factor-alpha, butit is noteworthy that transforming growth fac-
tor-beta has apredominantly negative regulatory effect on cell growth, through the induc-
tion of gastric epithelial cell apoptosis [26]. Thus, a lack of transforming growth factor-
beta or an inability to respond to this peptide due to a mutation in the type II receptor, as
occur in gastric carcinogenesis [27], would also result in decreased gastric epithelial cell
apoptosis. Finally, an increasingly complex pathway to activate apoptosis occurs through
the family of tumor necrosis factor receptors, stimulated by binding tumor necrosis fac-
tor or the Fas ligand and resulting in the activation of intracellular kinase cascades and
ultimately transcriptional regulation [28]. Since tumor necrosis factor-alpha is one of the
pro-inflammatory cytokines increased in the mucosa of H. pylori infected gastritis, this
may well be a key promoter of apoptosis in the gastric epithelium. Once apoptotic path-
ways are activated, there is a common late downstream regulatory step that determines
whether apoptosis will ultimately occur. This step is dependent upon regulation by the
Bcl-2 family ofproteins, some of which may be altered in H. pylori gastritis [29] and in
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Figure 6. Model to explain how the relationship between gastric apoptosis (A) and prolifera-
tion (P) can determine clinical outcome. The direction followed by any one patient may be depen-
dent upon the factors in the box: bacterial cagA genotype, epithelial cell p53 status and mutation of
the TGF-beta type II receptor, among others.
the later stages of gastric cancer [30]. We have little idea of the relative importance of
each of these pathways and their regulatory molecules in the normal stomach. However,
the Fas pathway has been implicated in a mouse model ofautoimmune gastritis [31], and
Mannick and colleagues have recently suggested that nitric oxide synthesis in the mucosa
of H. pylori-infected gastritis may promote apoptosis through inducing DNA damage
[32].
SUMMARY AND CONCLUSION
Chronic H. pylori infection may increase gastric epithelial cell proliferation by caus-
ing a higher than normal rate of apoptosis. How H. pylori induces apoptosis is not clear.
After an initial phase ofincreased cellular turnover manifested by increased "physiologi-
cal" apoptosis and increased cell proliferation, a shift in the balance between apoptosis
and proliferation may result in dysregulated tissue growth. What precisely is responsible
for this dysregulation is unclear. Candidates include the cagA phenotype of the bacteria,
the acquisition of a mutation ofp53 or the transforming growth factor-beta type II recep-
tor, or other factors capable of regulating proliferation, apoptosis and the cell cycle.
Although our knowledge of the relationship between proliferation and apoptosis in the
stomach is still at a very early stage, it is possible to construct a model to test some
hypotheses (Figure 6). In this model, thebalance orimbalance between apoptosis andpro-
liferation is assumed to determine the outcome ofinfection. Whether chronic gastritis pro-
gresses to ulcers and atrophy, or to cancer, may depend upon bacterial factors (such as the
cagA phenotype) and perhaps more importantly, epithelial cell determinants (for example,
p53 status, the transforming growth factor-beta type II receptor and Bcl-2 family expres-
sion). It is likely that in the future other epithelial cell regulatory molecules, oncogenes or
tumor suppressor genes, which determine the outcome ofinfection with H. pylori, will be
identified. Finally, it should be emphasized again that it is the relationship between apop-
tosis andproliferation that is important ratherthan apoptosis per se. Apoptosis is a healthy
phenomenon when activated at the end of the cell life span, or when appropriately acti-
vated to eliminate cells carrying mutations. It is only when inappropriately activated or
inhibited that abnormalities of apoptosis may contribute to disease. Understanding the
normal control ofapoptosis in gastric epithelial cells will help determine whether an inter-
action ofH. pylori with the epithelium will result in deleterious consequences.
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